Safety of octreotide in hospitalized infants

BACKGROUND: Octreotide is used off-label in infants for treatment of chylothorax, congenital hyperinsulinism, and gastrointestinal bleeding. The safety profile octreotide in hospitalized infants has not been described; we sought to fill this information gap. METHODS: We identified all infants expose...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Early Hum Dev
Asıl Yazarlar: Testoni, Daniela, Hornik, Christoph P., Neely, Megan L., Yang, Qinghong, McMahon, Ann W., Clark, Reese H., Smith, P. Brian
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2015
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC4450124/
https://ncbi.nlm.nih.gov/pubmed/25968047
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.earlhumdev.2015.04.008
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller